Literature DB >> 2395795

Relationships in the structure-tissue distribution of basic drugs in the rabbit.

K Yokogawa1, E Nakashima, J Ishizaki, H Maeda, T Nagano, F Ichimura.   

Abstract

The relationship between the tissue-to-plasma partition coefficients (Kp) and drug lipophilicity was investigated using highly lipophilic drugs with apparent partition coefficients of 150 or above in an octanol-water system at pH 7.4. Ten clinically popular basic drugs with different dissociation coefficients (pKa) and lipophilicity were used. The Kp values were determined in nondisposing organs after the i.v. administration of individual drugs in rabbits. The free fraction in plasma and the blood-to-plasma concentration ratio were determined in vitro. Then the tissue-to-plasma ratios of nonionized and unbound drug concentrations (Kpfu) were calculated from Kpf (ratio of unbound drug). The true octanol-water partition coefficient of the nonionized drugs (P) was used to analyze the Kpf and Kpfu. In all tissues, log Kpfu was more highly correlated with log P than log Kpf.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395795     DOI: 10.1023/a:1015803202857

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Absorption of drugs from the rat small intestine.

Authors:  L S SCHANKER; D J TOCCO; B B BRODIE; C A HOGBEN
Journal:  J Pharmacol Exp Ther       Date:  1958-05       Impact factor: 4.030

2.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Authors:  S Ohkuma; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

3.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; H Harashima; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

4.  Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma.

Authors:  M K Romach; K M Piafsky; J G Abel; V Khouw; E M Sellers
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

5.  Mutual effects of amino-beta-lactam antibiotics and glycylglycine on the transmural potential difference in the small intestinal epithelium of rats.

Authors:  E Nakashima; A Tsuji
Journal:  J Pharmacobiodyn       Date:  1985-08

6.  In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distribution.

Authors:  D J Greenblatt; R M Arendt; D R Abernethy; H G Giles; E M Sellers; R I Shader
Journal:  Br J Anaesth       Date:  1983-10       Impact factor: 9.166

7.  Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs.

Authors:  T Terasaki; T Iga; Y Sugiyama; M Hanano
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

8.  Effects of fasting on biperiden pharmacokinetics in the rat.

Authors:  E Nakashima; K Yokogawa; F Ichimura; T Hashimoto; T Yamana; A Tsuji
Journal:  J Pharm Sci       Date:  1987-01       Impact factor: 3.534

9.  Effects of cimetidine on quinidine distribution and tissue pH in rats.

Authors:  S Shibasaki; Y Kawamata; R Nishigaki; K Umemura
Journal:  J Pharmacobiodyn       Date:  1989-06

Review 10.  Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.

Authors:  Y Sawada; M Hanano; Y Sugiyama; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1985-10
View more
  12 in total

1.  Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicity.

Authors:  I Nestorov; L Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

2.  Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system.

Authors:  Oula Penate Medina; Nagavarakishore Pillarsetty; Athanasios Glekas; Blesida Punzalan; Valerie Longo; Mithat Gönen; Pat Zanzonico; Peter Smith-Jones; Steven M Larson
Journal:  J Control Release       Date:  2010-11-01       Impact factor: 9.776

Review 3.  Micellar nanocarriers: pharmaceutical perspectives.

Authors:  V P Torchilin
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.200

4.  The subcellular distribution of small molecules: a meta-analysis.

Authors:  Nan Zheng; Hobart Ng Tsai; Xinyuan Zhang; Kerby Shedden; Gus R Rosania
Journal:  Mol Pharm       Date:  2011-08-17       Impact factor: 4.939

Review 5.  Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.

Authors:  Pilar de la Puente; Abdel Kareem Azab
Journal:  Eur J Haematol       Date:  2017-03-28       Impact factor: 2.997

6.  Toxicological analysis of the psychotropic drugs chlorpromazine and diazepam using chemically fixed organ tissues.

Authors:  J Nishigami; T Takayasu; T Ohshima
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

7.  Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: role of plasma protein and tissue phosphatidylserine binding.

Authors:  K Hanada; S Akimoto; K Mitsui; K Mihara; H Ogata
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

8.  Toxicological analysis of drugs and poisons in formalin-fixed organ tissues. 2. Volatile substances.

Authors:  T Takayasu; K Saito; J Nishigami; T Ohshima; T Nagano
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

Review 9.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging.

Authors:  Vladimir P Torchilin
Journal:  AAPS J       Date:  2007-05-11       Impact factor: 4.009

10.  Contribution of lysosomes to the subcellular distribution of basic drugs in the rat liver.

Authors:  J Ishizaki; K Yokogawa; M Hirano; E Nakashima; Y Sai; S Ohkuma; T Ohshima; F Ichimura
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.